NIS – Newly Independent States; CA – Central Asia. According to John Hopkins University Covid-19 has already killed over 80,000 people and infected 1.4 mln others globally as of the beginning of April 2020. Governments around the globe introduce efforts to fight the novel virus: from radical to very moderate. Some are already starting to weaken measures amid the risk of economic collapse. We accumulated key efforts done by the Ukrainian government to face this problem. This publication is a part of our regional NIS/CA Life Sciences Markets Monitor.Read more
"CIS Pharmaceutical Markets Landscape 2019" gives a general view of the pharmaceutical markets of 7 ex-Soviet countries by comparing the key indicators and describing the main pharmaceutical distributors. This publication will help you, having tested the main landscape, to get an idea of the surveyed markets, and maybe to determine a general plan for further access to them.Read more
This publication reveals the main characteristics of pharmaceutical regulation in seven CIS countries. It covers the issues of marketing authorization, import control, price regulation, and promotion of pharmaceutical products.Read more
The current Report uncovers the 2019 business trends of the pharmaceutical market of the Russian Federation, overviews its healthcare system, portrays its epidemiology and demographics. It also depicts pharma regulation features in Russia including a step-by-step process of the marketing authorization for pharmaceutical products. It provides insight into the country’s socio-political development since independence, describes recent economic trends, and provides pharmaceutical market forecast for the next three years (2020-2022).Read more
Overview of the Ukrainian pharmaceutical market latest trends in June 2019. Country's current economic indicators and trends, economy updates, drug companies and products, healthcare news and regulatory updates. We have added a new section — life sciences markets news in the CIS region.